Related Experiment Video
Updated: Apr 5, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Pharmacological Treatment in Upper Gastrointestinal Bleeding
Kelvin L Y Lam1, John C T Wong1, James Y W Lau2
1Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, 9th floor, Clinical Science Building, 30-32 Ngan Shing Street, Shatin, Hong Kong.
Acute upper gastrointestinal bleeding (AUGIB) requires prompt management. Pharmacotherapy, including acid suppression for ulcers and vasoactive drugs for varices, significantly aids endoscopic therapy and improves patient outcomes.
Area of Science:
- Gastroenterology
- Internal Medicine
Background:
- Acute upper gastrointestinal bleeding (AUGIB) is a frequent medical emergency.
- Peptic ulcers are the most common cause of AUGIB, while variceal bleeding is more severe in cirrhotic patients.
Purpose of the Study:
- To review pharmacotherapeutic strategies for AUGIB.
- To discuss acid suppression for peptic ulcers and vasoactive agents/antibiotics for variceal bleeding.
- To examine tranexamic acid's role in gastrointestinal bleeding.
Main Methods:
- Review of current literature on pharmacotherapy for AUGIB.
- Analysis of evidence for acid suppression, vasoactive agents, antibiotics, and tranexamic acid.
- Discussion of treatment strategies in relation to endoscopic therapy.
Main Results:
- Acid suppression reduces re-bleeding and interventions for peptic ulcers.
- Vasoactive agents and antibiotics decrease mortality in variceal bleeding.
- Early pharmacotherapy can facilitate endoscopic procedures and improve outcomes.
Conclusions:
- Pharmacotherapy is crucial in managing AUGIB, complementing endoscopic interventions.
- Tailored medical management improves outcomes for both peptic ulcer and variceal bleeding.
- Further evidence supports tranexamic acid's utility in specific GI bleeding scenarios.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

